179 related articles for article (PubMed ID: 15477300)
1. Anticancer vaccination strategies.
Nencioni A; Grüenbach F; Patrone F; Brossart P
Ann Oncol; 2004; 15 Suppl 4():iv153-60. PubMed ID: 15477300
[No Abstract] [Full Text] [Related]
2. New cancer vaccine approaches.
Kaplan JM
Drugs Today (Barc); 2004 Nov; 40(11):913-29. PubMed ID: 15645004
[TBL] [Abstract][Full Text] [Related]
3. Genetically modified tumour vaccines--where we are today.
Nawrocki S; Mackiewicz A
Cancer Treat Rev; 1999 Feb; 25(1):29-46. PubMed ID: 10212588
[TBL] [Abstract][Full Text] [Related]
4. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
Srivastava PK
Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors.
Blachere NE; Srivastava PK
Semin Cancer Biol; 1995 Dec; 6(6):349-55. PubMed ID: 8938273
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-peptide complexes for use in vaccines.
Heike M; Noll B; Meyer zum Büschenfelde KH
J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines.
Pardoll DM
Nat Med; 1998 May; 4(5 Suppl):525-31. PubMed ID: 9585204
[No Abstract] [Full Text] [Related]
8. Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.
Srivastava PK; Jaikaria NS
Methods Mol Biol; 2001; 156():175-86. PubMed ID: 11068759
[No Abstract] [Full Text] [Related]
9. Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.
Quatan N; Spicer J; Plunkett T; Pandha H
Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):356-65. PubMed ID: 15341440
[No Abstract] [Full Text] [Related]
10. Heat shock protein-peptide complexes in cancer immunotherapy.
Srivastava PK; Udono H
Curr Opin Immunol; 1994 Oct; 6(5):728-32. PubMed ID: 7826528
[TBL] [Abstract][Full Text] [Related]
11. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines.
Heike M; Weinmann A; Bethke K; Galle PR
Biochem Pharmacol; 1999 Nov; 58(9):1381-7. PubMed ID: 10513981
[TBL] [Abstract][Full Text] [Related]
12. Cancer vaccination.
Del Vecchio M; Parmiani G
Forum (Genova); 1999; 9(3):239-56. PubMed ID: 10504171
[TBL] [Abstract][Full Text] [Related]
13. Heat shock proteins and their use as anticancer vaccines.
Parmiani G; Testori A; Maio M; Castelli C; Rivoltini L; Pilla L; Belli F; Mazzaferro V; Coppa J; Patuzzo R; Sertoli MR; Hoos A; Srivastava PK; Santinami M
Clin Cancer Res; 2004 Dec; 10(24):8142-6. PubMed ID: 15623587
[No Abstract] [Full Text] [Related]
14. Heat shock proteins and cancer immunotherapy.
Wang XY; Kaneko Y; Repasky E; Subjeck JR
Immunol Invest; 2000 May; 29(2):131-7. PubMed ID: 10854181
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein-peptide complex in the treatment of glioblastoma.
See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M
Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein--peptide complexes as immunotherapy for human cancer.
Przepiorka D; Srivastava PK
Mol Med Today; 1998 Nov; 4(11):478-84. PubMed ID: 9857367
[TBL] [Abstract][Full Text] [Related]
17. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
[TBL] [Abstract][Full Text] [Related]
18. Cancer vaccines: finding the best way to train the immune system.
Goldman B
J Natl Cancer Inst; 2002 Oct; 94(20):1523-6. PubMed ID: 12381703
[No Abstract] [Full Text] [Related]
19. Heat shock proteins (HSPs) based anti-cancer vaccines.
Ciocca DR; Cayado-Gutierrez N; Maccioni M; Cuello-Carrion FD
Curr Mol Med; 2012 Nov; 12(9):1183-97. PubMed ID: 22804241
[TBL] [Abstract][Full Text] [Related]
20. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
Zöller M; Matzku S
Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
